Kim HS, Kim SO, Kim BS. Use of a clinical pathway in laparoscopic gastrectomy for gastric cancer. World J Gastroenterol 2015; 21(48): 13507-13517 [PMID: 26730162 DOI: 10.3748/wjg.v21.i48.13507]
Corresponding Author of This Article
Byung Sik Kim, MD, PhD, Professor of Medicine, Department of Gastric Surgery, Asan Medical Center, Ulsan University, 88, Olympic-Ro 43-Gil, Seoul 138-736, South Korea. bskim@amc.seoul.kr
Research Domain of This Article
Surgery
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Dec 28, 2015; 21(48): 13507-13517 Published online Dec 28, 2015. doi: 10.3748/wjg.v21.i48.13507
Table 1 Structure of the clinical pathway for laparoscopic gastrectomy
Activities date
1 d before OP (Admission)
Pre-OP (the day of OP)
Operation(the day of OP)
Post-OP(the day of OP)
POD 1
POD 2
POD 3
POD 4
POD 5 and 6 (D/C)
Nursing care
Admission to room: (1-3 pm)Fluid balanceSurveillance V/SWeight measurement
Room nurse:Fluid balance,Check V/S
Surgical nurse:OP preparation
Room nurse:Fluid balanceCheck V/S,drainage
Room nurse:Fluid balanceCheck V/S,drainage
Room nurse:Fluid balanceCheck V/S,drainage
Room nurse: Fluid balance, Check V/S, Drainage
Room nurse:Check V/S
Room nurse:Check V/S
Check (Surgeon/anesthesiologist): Preoperative study Written consentProtocol for OP preparation
Remove peripheral line after start of 2nd SD
Activity
Usual
Bed rest
Bed rest
Bed rest
Ambulation
Ambulation
Ambulation
Ambulation
Ambulation
Treatment procedure
Skin preparation No Levin tube Breathing exercises use of IS Bowel preparation: Magcorol solution, 250 mL: Dulcolax supplement, 2 sup
Surgical nurse:Foley catheterInsertion
Breathingexercises: use of IS
Breathing exercises: use of IS
Breathing exercises: use of IS
Breathing exercises: use of ISremove JP
Surgeon:Wound S/OEvaluation on D/C criteria
Surgeons: OP
Anesthesiologist:PCA (Fentanyl 3000 mg)
Medication
Prophylaxis: TE
Prophylaxis: ATB
Prophylaxis: ATBMucolytic agent
Prophylaxis: TE
Anesthesiologist: PCA
PCA
PCA
Medication on demand
Pain killer: (IV) Demerol NSAIDs Antiemetics
Pain killer: (IV)Demerol NSAIDs Antiemetics
Pain killer: (IV)Demerol NSAIDs Antiemetics
Pain killer: (IV)Demerol NSAIDs Antiemetics
Pain killer: (Oral) NSAIDs
Pain killer: (Oral) NSAIDs
Laboratory test
Laboratorytest
Laboratory test
Laboratorytest
Laboratorytest
Diet
Usual diet at breakfastNPO after breakfast
NPO
NPO
NPO
SOW: post 24 h OP
LD at breakfastSD after G/O
SD
SD
Education and information
Information on CPPermission
Information on leaving OP room
Education: diet for patient and/or relative
Education: diet for patient and/or relative
Information on D/C
Table 2 Demographic data for the enrolled patients n (%)
Variables
No. of patients (total n = 4800)
Sex
Male:Female
2920:1880 (60.8:39.2)
Age (yr)
mean ± SD
56.7 ± 11.7
BMI (kg/m2)
mean ± SD
23.71 ± 3.0
Anastomosis method
Intra:Extra
2345:2455 (48.9:51.1)
Resection
Distal:Total
4218:582 (87.9:12.1)
Combined OP
None:Yes
4531:269 (94.4:5.6)
Event during OP
None:Yes
4723:77 (98.4:1.6)
Number of comorbidities
0:1:2 and more
3196:1137:467 (66.6:23.7:9.7)
ASA
1:2:3
3025:1549:226 (63.0:32.3:4.7)
Previous Abd. OP history
N:Y
4057:743 (84.5:15.5)
TNM stage
1:2:3
4380:314:106 (91.3:6.5:2.2)
Table 3 Events during operation
Intra (n = 25)
Extra (n = 52)
Anastomosis failure (n = 31)
8
23
Esophagojejunostomy failure
7
9
Gastroduodenostomy failure
1
14
Organ injury (n = 30)
10
20
Spleen injury
6
10
Duodenum
0
5
Small bowel injury
1
1
Colon injury
1
2
Pancreas injury
1
1
Liver injury
1
1
Vessel injury (n = 12)
4
8
Splenic artery injury
2
6
Splenic vein injury
0
1
Common hepatic artery injury
1
1
Proper hepatic artery injury
1
0
Emphysema (n = 4)
3
1
Table 4 Clinicopathological characteristics of patients who underwent total laparoscopic gastrectomy (intracorporeal anastomosis) and laparoscopic assisted gastrectomy (extracorporeal anastomosis) n (%)
Citation: Kim HS, Kim SO, Kim BS. Use of a clinical pathway in laparoscopic gastrectomy for gastric cancer. World J Gastroenterol 2015; 21(48): 13507-13517